Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126861451 | 12686145 | 1 | I | 20160630 | 20160815 | 20160825 | 20160825 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-53545BP | BOEHRINGER INGELHEIM | 72.33 | YR | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126861451 | 12686145 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG | 21698 | 150 | MG | TABLET | |||||||
| 126861451 | 12686145 | 2 | C | ANAPRIL | ENALAPRIL MALEATE | 1 | Oral | 300 MG | 0 | 300 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 3 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 6 ANZ | 0 | CAPSULE | TID | ||||||||
| 126861451 | 12686145 | 4 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG | 0 | 20 | MG | CAPSULE | BID | ||||||
| 126861451 | 12686145 | 5 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 1 ANZ | 0 | TABLET | QD | ||||||||
| 126861451 | 12686145 | 6 | C | PROBIOTIC | PROBIOTICS NOS | 1 | Oral | 0 | CAPSULE | BID | |||||||||
| 126861451 | 12686145 | 7 | C | DUCOSATE SODIUM | 2 | Oral | 200 MG | 0 | 100 | MG | CAPSULE | BID | |||||||
| 126861451 | 12686145 | 8 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 125 MCG | 0 | 125 | UG | TABLET | QD | ||||||
| 126861451 | 12686145 | 10 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 2000 U | 0 | 2000 | IU | CAPSULE | QD | ||||||
| 126861451 | 12686145 | 11 | C | BIOTIN | BIOTIN | 1 | Oral | 1000 MCG | 0 | 500 | UG | TABLET | BID | ||||||
| 126861451 | 12686145 | 12 | C | KRILL OIL | DIETARY SUPPLEMENT | 1 | Oral | 750 MG | 0 | 750 | MG | CAPSULE | QD | ||||||
| 126861451 | 12686145 | 13 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Oral | 60 MG | 0 | 60 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 14 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 15 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG | 0 | 81 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 16 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 17 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 18 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 200 MG | 0 | 200 | MG | TABLET | QD | ||||||
| 126861451 | 12686145 | 19 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25 MG | 0 | .25 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126861451 | 12686145 | 1 | Dyspepsia |
| 126861451 | 12686145 | 2 | Hypertension |
| 126861451 | 12686145 | 3 | Diabetes mellitus |
| 126861451 | 12686145 | 4 | Depression |
| 126861451 | 12686145 | 5 | Hypersensitivity |
| 126861451 | 12686145 | 6 | Product used for unknown indication |
| 126861451 | 12686145 | 7 | Constipation |
| 126861451 | 12686145 | 8 | Hypertonic bladder |
| 126861451 | 12686145 | 9 | Hypothyroidism |
| 126861451 | 12686145 | 10 | Product used for unknown indication |
| 126861451 | 12686145 | 11 | Product used for unknown indication |
| 126861451 | 12686145 | 12 | Product used for unknown indication |
| 126861451 | 12686145 | 13 | Tremor |
| 126861451 | 12686145 | 14 | Blood cholesterol increased |
| 126861451 | 12686145 | 15 | Product used for unknown indication |
| 126861451 | 12686145 | 16 | Product used for unknown indication |
| 126861451 | 12686145 | 17 | Diabetes mellitus |
| 126861451 | 12686145 | 18 | Product used for unknown indication |
| 126861451 | 12686145 | 19 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126861451 | 12686145 | Chest pain | |
| 126861451 | 12686145 | Drug ineffective | |
| 126861451 | 12686145 | Hiccups |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126861451 | 12686145 | 1 | 201605 | 0 | ||
| 126861451 | 12686145 | 2 | 2012 | 0 | ||
| 126861451 | 12686145 | 8 | 201608 | 0 | ||
| 126861451 | 12686145 | 17 | 201607 | 0 |